Inventor

TOWART ROBERTSON

DE22 patents

⚠️ This page may combine multiple inventors who share the name “TOWART ROBERTSON”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

TOWART ROBERTSON

BAYER AG

Method of combatting coronary and vascular diseases

The compound, (⃡)1,4-dihydro-2,6-dimethyl-4-(2&#39;-nitrophenyl)-pyridine-3,5-dicarboxylic acid, methyl isobutyl ester, compositions containing same and a method for effecting coronary dilation

Nitro-substituted 1,4-dihydropyridines, processes for _their production and their medicinal use

1,4-Dihydropyridine derivatives substituted in the 2 position, and their use as medicaments

1,4-Dihydro-2,6-dimethyl-4-(2&#39;-chlorophenyl)-3,5-dicarboxylic acid,methyl or ethyl,trifluoroethyl ester

2-Alkyleneaminodihydropyridines compounds, their production and their medicinal use

Optically active 1,4-dihydropyridine esters useful for treating circulatory illnesses

Substituted 2-amino-3,4-dihydropyridine derivatives, their production and their medicinal use

Sila-substituted 1,4-dihydropyridine derivatives and their medicinal use

1,4-Dihydropyridazine compounds, and their medicinal use

1,4-Dihydropyridazine compounds

1,4-Dihydropyridazine-3-carboxylic acid derivatives, a process for their preparation and their use as antihypertensives

Use of sulphonyldihydropyridines as medicaments for the treatment of asthma

NYCOMED IMAGING AS

Reduction of cardiotoxicity of an antitumor agent using manganese compound

Use of chelating agents in the treatment of atherosclerotic conditions

Chelating agents and their metal chelates for treating free radical induced conditions

PUGH RANDALL B

Light therapy system including spectacle frames and contact lenses

Apparatus and method for formation of an energized ophthalmic device for light therapy

AMERSHAM HEALTH AS

Nitric oxide releasing chelating agents and their therapeutic use

CAMBRIDGE BIOCLINICAL LTD

Potassium channel activators and their use

HAFSLUND NYCOMED PHARMA

Heterocyclic amides

JOHNSON & JOHNSON VISION CARE

Spectacles for light therapy

The compound, (⃡)1,4-dihydro-2,6-dimethyl-4-(2'-nitrophenyl)-pyridine-3,5-dicarboxylic acid, methyl isobutyl ester, compositions containing same and a method for effecting coronary dilation

1,4-Dihydro-2,6-dimethyl-4-(2'-chlorophenyl)-3,5-dicarboxylic acid,methyl or ethyl,trifluoroethyl ester